Atossa Therapeutics
ATOS
#10505
Rank
C$33.25 M
Marketcap
C$3.33
Share price
-1.87%
Change (1 day)
174.64%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -C$51.88 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$49.02 Million a decrease over its 2024 earnings that were of -C$35.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$51.88 Million5.82%
2025 -C$49.02 Million36.33%
2024 -C$35.96 Million-15.25%
2023 -C$42.43 Million11.62%
2022 -C$38.01 Million30.84%
2021 -C$29.06 Million15.58%
2020 -C$25.14 Million3.41%
2019 -C$24.31 Million51.16%
2018 -C$16.08 Million40.41%
2017 -C$11.46 Million27.54%
2016 -C$8.98 Million-47.49%
2015 -C$17.1 Million-17.25%
2014 -C$20.67 Million35.91%
2013 -C$15.21 Million112.3%
2012 -C$7.17 Million46.53%
2011 -C$4.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.62 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.93 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$1.93 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$58.76 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$0.15 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$11.06 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA